ArticleCirculation reports2025
Electrocardiographic Prediction of Acute Pulmonary Embolism at Intermediate-High- and High-Risk.
Article in Circulation reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Comparison of Clinical Outcomes of Venous Thromboembolism Between Weekend Diagnosis and Weekday Diagnosis in the Direct Oral Anticoagulant Era: Insights From the COMMAND VTE Registry-2.Circulation reports · 2026Article
- Reperfusion Therapy and Outcomes in High-Risk Pulmonary Embolism: Multicenter Registry Study From the Tokyo Cardiovascular Care Unit Network.Circulation reports · 2026Article
- Artificial Intelligence-Driven Integration of ECG and Molecular Biomarkers in Pulmonary Embolism.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute pulmonary embolism (PE) is a life-threatening condition, and the diagnosis of acute PE remains difficult. Methods and Results: In all, 133 consecutive patients with acute PE (mean [±SD] age 72±17 years, 53 men) were classified into 4 groups based on the severity of PE: high risk (n=12); intermediate-high risk (n=86); intermediate-low risk (n=1); and low risk (n=34). After excluding the 1 patient with intermediate-low-risk PE, clinical characteristics, the high-, intermediate-high-, and low-risk groups were compared: T wave inversion (V1-V3) was seen in 83%, 56%, and 18% of patients, respectively (P<0.001); an S1Q3T3 pattern was seen in 75%, 35%, and 0% of patients, respectively (P<0.001); echocardiographic evidence of right ventricular (RV) dysfunction was seen in 100%, 86%, and 0% of patients, respectively (P<0.001); the median (interquartile range) door-to-treatment time (n=11, 44, and 15, respectively) was 65 (43-116), 116 (78-213), and 183 (104-222) min, respectively (P<0.01); and the in-hospital death rate was 50%, 1%, and 0%, respectively (P<0.001). Multivariate analysis revealed that T wave inversion and an S1Q3T3 pattern were independently associated with intermediate-high- and high-risk acute PE, with adjusted odds ratios (95% confidence intervals) of 5.85 (2.14-15.96; P=0.0006) and 4.31 (1.65-11.27; P=0.0029), respectively. Conclusions: Electrocardiographic evidence of right precordial T wave inversion and an S1Q3T3 pattern, followed by echocardiographic confirmation of RV dysfunction, may help with the early diagnosis of intermediate-high- and high-risk acute PE and thus contribute to improved door-to-treatment times and the prevention of adverse outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.